Glycoprotein 130 can transfer to macrophages via BC-derived sEVs, leading to phosphorylation of transcription factor STAT3 and induction of tumourigenesis-associated genes IL-6 and IL-10 [179], suggesting the potential of both glycoprotein 130 and CD147 as biomarkers for BC progression monitoring. The gene discussed is IL6; the disease is breast cancer.